Back to search

Article

The impact of Bevacizumab on mucosal healing after dental extraction in patients undergoing cancer treatment in the central region of Algeria

2024-01-05

Abstract excerpt

<title>Abstract</title> <p><bold>Objectives:</bold> Bevacizumab currently stands as the most prescribed anti-VEGF medication in oncology. It functions as an angiogenesis inhibitor, thereby slowing down tumor progression. However, this drug is associated with side effects both in general health and in the oral cavity. To assess the impact of Bevacizumab on mucosal healing after dental extraction in patients underg...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bb3fe35d-8d88-514b-b24e-05bb49b96428
DOI
10.21203/rs.3.rs-3689262/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The impact of Bevacizumab on mucosal healing after dental extraction in patients undergoing cancer treatment in the central region of AlgeriaDOI 10.21203/rs.3.rs-3689262/v1
Select a neighboring publication to make it the new centre.